CRISIL upgrades Global Health long-term rating to AA/Stable from AA-/Positive

Rating UpgradedCredit & Debt View source PDF Explain this filing

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹1141.40

prior close

₹1147.20

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.5%+0.5% vs market

Hospital peers, median of 20sector-1.3%+1.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Midcap 150 and 1.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-0.9

15m

-0.8

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1-0.5+0.5-1.3+1.2

Next day

+0.6-0.3+0.9-2.2+2.8

+2.5+0.8+1.7-1.4+3.9

+2.3+1.7+0.7-0.8+3.2

+3.8+1.8+2.1-1.0+4.8

+4.3+1.3+3.0-0.9+5.2

+1.1+0.6+0.5-1.3+2.4

15d

+5.5+1.0+4.5-3.4+8.9

-2.5-0.4-2.1-6.6+4.1

+2.9+0.3+2.6-7.9+10.8

-8.8-7.3-1.5-14.9+6.1

UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CRISIL upgraded Global Health's (Medanta) long-term rating to AA/Stable from AA-/Positive on total bank loan facilities of Rs 1,500 crore. Short-term rating reaffirmed at A1+. Lenders include SBI, ICICI, HDFC and Yes Bank. The upgrade reflects stronger credit profile, though outlook moved from Positive to Stable.

Likely market impact

Positive signal of stronger creditworthiness and lower borrowing cost potential. Stable outlook indicates no near-term further upgrade expected.